HuagongsheHuagongshe Chemie-Druckbericht · Nur für Forschungszwecke
HCID 21073199, Verbindung → 7-{4-[4-(1-Methyl-2-oxo-1,2,3,4-tetrahydro-quinolin-8-yl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-one
Beteiligte Stoffe
| Rolle | Name | HCID | Einwaage |
|---|---|---|---|
| Edukt | HCID 21073199 | HCID 21073199 | — |
| Edukt | 4-((7-Oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)oxy)butanal | HCID 21073377 | — |
| Produkt | 7-{4-[4-(1-Methyl-2-oxo-1,2,3,4-tetrahydro-quinolin-8-yl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-[1,8]naphthyridin-2-one | HCID 21073496 | — |
Reaktionsschritte
In a manner similar to that of other examples above, 1-methyl-8-piperazin-1-yl-3,4-dihydro-1H-quinolin-2-one hydrochloride was coupled by reductive amination to 4-(7-oxo-5,6,7,8-tetrahydro-[1,8]naphthyridin-2-yloxy)-butyraldehyde followed by typical workup and purification to give the title compound. MS: APCI: M+1: 464.6 (Exact Mass: 463.26).
Herkunft & Nachweise
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| Patentnummer | US07160888B2 |
| Quelldatensatz | uspto-grants-2007_01 |
| ORD ID | ord-0bc9d3d5ab284f18abf4848f41bc88ec |
| Quellennotiz | uspto-grants-2007_01 |